The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...
The Minimal Residual Disease Testing Market is projected to reach $4.45 billion by 2031, at a CAGR of 14.6% during the forecast period 2024–2031. The growth of the minimal residual disease testing ...